학술논문

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 20 2021, 39 6, 4p. Supplement: S
Subject
Language
English
ISSN
15277755